BioMarin Pharmaceutical revenue and financials
$57.54Change from previous close: +0.63%Absolute change: +$0.36
In the fiscal year ended December 2025, BioMarin Pharmaceutical reported revenue of $3.22B (+12.87% year over year). Net income was $348.9M, a net margin of 10.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +12.87%
- 2025 vs 2024
- Net income growth
- −18.26%
- 2025 vs 2024
- Net margin
- 10.8%
- 2024: 15.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3,221 | 2,854 | 2,419 | 2,096 | 1,846 | 1,860 | 1,704 | 1,491 | 1,314 | 1,117 |
| Cost of revenue | 717 | 580 | 532 | 503 | 471 | 524 | 359 | 315 | 242 | 210 |
| Gross profit | 1,701 | 1,526 | 1,140 | 943 | 747 | — | — | — | — | — |
| Selling, general and administrative | 1,031 | 1,009 | 892 | 823 | 759 | — | — | — | — | — |
| Research and development | 922 | 747 | 747 | 650 | 629 | 628 | 715 | 696 | 611 | 662 |
| Operating income | 409 | 484 | 186 | 161 | -82.3 | -43.4 | -100 | -124 | -14.7 | -803 |
| EBIT | 651 | 474 | 186 | 54.7 | -74.3 | — | — | — | — | — |
| EBITDA | 723 | 571 | 290 | 157 | 33.7 | — | — | — | — | — |
| Interest expense | 10.9 | 12.7 | 17.3 | 16.0 | 15.3 | 29.3 | 23.5 | 43.7 | 42.7 | 39.5 |
| Pre-tax income | 482 | 542 | 189 | 150 | -75.4 | — | — | — | — | — |
| Income tax | 134 | 115 | 20.9 | 8.0 | -11.3 | -903 | -71.0 | -65.5 | 81.2 | -201 |
| Net income | 349 | 427 | 168 | 142 | -64.1 | 854 | -23.8 | -77.2 | -117 | -630 |
| Net income to common shareholders | 349 | 427 | 168 | 142 | -64.1 | — | — | — | — | — |
| Basic EPS | 1.82 | 2.25 | 0.89 | 0.76 | -0.35 | 4.72 | -0.13 | -0.44 | -0.67 | -3.80 |
| Diluted EPS | 1.80 | 2.21 | 0.87 | 0.75 | -0.35 | 4.50 | -0.13 | -0.44 | -0.67 | -3.81 |
| Average shares (basic) | 192 | 190 | 188 | 185 | 183 | — | — | — | — | — |
| Average shares (diluted) | 197 | 197 | 192 | 189 | 183 | 192 | 179 | 177 | 174 | 166 |